← FDA Drug Approvals (Drugs@FDA)

ALUNBRIG

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2017-04-28

Drug application

FDA Application #

NDA208772

Application type

New Drug Application

Brand name

ALUNBRIG

Generic name

BRIGATINIB

Active ingredients

BRIGATINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2017-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown